Search
MSK researchers recently reported results of a phase 2 trial for GIST, a rare form of gastrointestinal cancer. The trial was based on years of lab work conducted by physician-scientist Ping Chi.
MSK was recently in the news regarding our relationship with a technology spin-off company called Paige.AI.
Memorial Sloan Kettering researchers will explore "C dots" for tumor detection and treatment.
MSK’s Pamela Drullinsky, MD, a breast medical oncologist and Regional Care Network Medical Site Director of MSK Nassau, joined one of her patients on a recent segment on Noticiero Telemundo 47 for breast cancer awareness month.
La Dra. Pamela Drullinsky, oncóloga médica de MSK especialista en mamas y directora médica del sitio de la Red Regional de Atención MSK Nassau, acompañó recientemente a una de sus pacientes en un segmento del Noticiero Telemundo 47 por el mes de concientización sobre el cáncer de mama.
Nikki Chotas, who uses the pronouns they/them, has dedicated much of their life to speaking up for and working to empower those who may feel helpless and without a voice. They attribute their pursuits in part to feeling voiceless in their younger years.
Cancer is tough, no matter the age. But adolescents and young adults with cancer face a whole host of unique challenges, including delayed diagnoses. MSK created an Adolescent and Young Adult (AYA at MSK) program which unites experts across 16 specialties.
Childhood leukemia expert Melvyn Greaves received The Society of Memorial Sloan Kettering Prize at the 2018 Gerstner Sloan Kettering Graduate School of Biomedical Sciences (GSK) commencement.
Learn about a three-drug treatment that has been shown to extend survival for ER+, HER2- breast cancers.
Watch our scientists discuss how the Geoffrey Beene Center helped Memorial Sloan Kettering establish a progressive approach to modern cancer research.